378 related articles for article (PubMed ID: 8901663)
61. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
62. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
[TBL] [Abstract][Full Text] [Related]
63. Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans.
Shirai N; Naruko T; Ohsawa M; Ikura Y; Sugama Y; Hirayama M; Kitabayashi C; Ehara S; Inoue T; Itoh A; Haze K; Tanzawa K; Yoshiyama M; Yoshikawa J; Ueda M
J Hypertens; 2006 Apr; 24(4):711-21. PubMed ID: 16531800
[TBL] [Abstract][Full Text] [Related]
64. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
65. Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
Ksander GM; Savage P; Trapani AJ; Balwierczak JL; Jeng AY
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S71-3. PubMed ID: 9595404
[TBL] [Abstract][Full Text] [Related]
66. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure.
Wada A; Tsutamoto T; Fukai D; Ohnishi M; Maeda K; Hisanaga T; Maeda Y; Matsuda Y; Kinoshita M
J Am Coll Cardiol; 1997 Nov; 30(5):1385-92. PubMed ID: 9350944
[TBL] [Abstract][Full Text] [Related]
67. The functional shift of endothelin receptor subtypes in dogs with heart failure produced by rapid ventricular pacing.
Tadano K; Hosokawa A; Fukuroda T; Nishikibe M
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S350-3. PubMed ID: 15838318
[TBL] [Abstract][Full Text] [Related]
68. Constriction of mouse hepatic venules and sinusoids by endothelins through ETB receptor subtype.
Ito Y; Katori M; Majima M; Kakita A
Int J Microcirc Clin Exp; 1996; 16(5):250-8. PubMed ID: 8951523
[TBL] [Abstract][Full Text] [Related]
69. Role of endothelium in vasomotor responses to endothelin system and protein kinase C activation in porcine retinal arterioles.
Potts LB; Bradley PD; Xu W; Kuo L; Hein TW
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7587-94. PubMed ID: 24243985
[TBL] [Abstract][Full Text] [Related]
70. [The relationship between endothelin receptors and chronic venous insufficiency of lower extremities].
Yang L; Qi GY; Cao YX; Liu J; Zhao M
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1325-8. PubMed ID: 19094564
[TBL] [Abstract][Full Text] [Related]
71. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo.
Haynes WG; Strachan FE; Webb DJ
Circulation; 1995 Aug; 92(3):357-63. PubMed ID: 7634449
[TBL] [Abstract][Full Text] [Related]
72. Endothelin ETA and ETB receptors mediate vasoconstriction and prostanoid release in the isolated kidney of the rat.
Warner TD; Battistini B; Allcock GH; Vane JR
Eur J Pharmacol; 1993 Dec; 250(3):447-53. PubMed ID: 8112405
[TBL] [Abstract][Full Text] [Related]
73. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
74. Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery.
Schilling L; Vatter H; Mursch K; Ehrenreich H; Schmiedek P
Peptides; 2000 Jan; 21(1):91-9. PubMed ID: 10704724
[TBL] [Abstract][Full Text] [Related]
75. Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion.
Skovsted GF; Kruse LS; Larsen R; Pedersen AF; Trautner S; Sheykhzade M; Edvinsson L
Br J Pharmacol; 2014 Jun; 171(11):2726-38. PubMed ID: 24467585
[TBL] [Abstract][Full Text] [Related]
76. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
77. Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.
Dimitrijevic I; Edvinsson ML; Chen Q; Malmsjö M; Kimblad PO; Edvinsson L
BMC Cardiovasc Disord; 2009 Aug; 9():40. PubMed ID: 19706169
[TBL] [Abstract][Full Text] [Related]
78. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle.
Maguire JJ; Johnson CM; Mockridge JW; Davenport AP
Br J Pharmacol; 1997 Dec; 122(8):1647-54. PubMed ID: 9422810
[TBL] [Abstract][Full Text] [Related]
79. Endothelin analogs which distinguish vasoconstrictor and vasodilator ETB receptors.
Natarajan S; Hunt JT; Festin S; Serafino R; Zhang R; Moreland S
Life Sci; 1995 Mar; 56(15):1251-6. PubMed ID: 8614242
[TBL] [Abstract][Full Text] [Related]
80. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade.
Burkhardt M; Barton M; Shaw SG
J Hypertens; 2000 Mar; 18(3):273-9. PubMed ID: 10726713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
